Starpharma Holdings Limited announces that after nearly 17 years with the Company, including 14 years as Chief Financial Officer (CFO), Mr. Nigel Baade, has advised of his intention to leave Starpharma in early 2023 to pursue new professional opportunities. Starpharma has commenced an executive search process for a new CFO. Mr. Baade will assist the Company in the transition until March 2023, completing the half year financial results.